Search Results for: Cell therapy

Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington’s disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.

Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington’s disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.

Huntington's Disease Literature
Publication date: Sep 17, 2019 3-Nitropropionic acid (3-NP) induces a spectrum of Huntington’s disease (HD)-like neuropathologies in the rat striatum. The present study aimed to demonstrate the neuroprotective effect of ... Read more